{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T15:34:33Z","timestamp":1781105673405,"version":"3.54.1"},"reference-count":20,"publisher":"Japanese Society for Pediatric Endocrinology","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Pediatr Endocrinol"],"published-print":{"date-parts":[[2023]]},"DOI":"10.1297\/cpe.2022-0077","type":"journal-article","created":{"date-parts":[[2023,2,17]],"date-time":"2023-02-17T17:12:51Z","timestamp":1676653971000},"page":"110-113","source":"Crossref","is-referenced-by-count":1,"title":["Safe administration of sotrovimab to a COVID-19 patient with acute phase type          1 diabetes mellitus"],"prefix":"10.1297","volume":"32","author":[{"given":"Haruna","family":"Tanaka","sequence":"first","affiliation":[{"name":"Department of Endocrinology and Metabolism, Hyogo              Prefectural Kobe Children\u2019s Hospital, Kobe, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaaki","family":"Matsumoto","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Hyogo              Prefectural Kobe Children\u2019s Hospital, Kobe, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung Won","family":"Hong","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Hyogo              Prefectural Kobe Children\u2019s Hospital, Kobe, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akari","family":"Mitsuboshi","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Hyogo              Prefectural Kobe Children\u2019s Hospital, Kobe, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masashi","family":"Nagai","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Hyogo              Prefectural Kobe Children\u2019s Hospital, Kobe, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Go","family":"Yoshino","sequence":"additional","affiliation":[{"name":"Division of Infectious Disease, Department of              Pediatrics, Hyogo Prefectural Kobe Children\u2019s Hospital, Kobe,            Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shogo","family":"Otake","sequence":"additional","affiliation":[{"name":"Division of Infectious Disease, Department of              Pediatrics, Hyogo Prefectural Kobe Children\u2019s Hospital, Kobe,            Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susumu","family":"Matsuo","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Toyooka Hospital, Hyogo,              Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Yamada","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Toyooka Hospital, Hyogo,              Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Kurosawa","sequence":"additional","affiliation":[{"name":"Division of Pediatric Critical Care Medicine, Hyogo              Prefectural Kobe Children\u2019s Hospital, Kobe, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masashi","family":"Kasai","sequence":"additional","affiliation":[{"name":"Division of Infectious Disease, Department of              Pediatrics, Hyogo Prefectural Kobe Children\u2019s Hospital, Kobe,            Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kayo","family":"Ozaki","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Hyogo              Prefectural Kobe Children\u2019s Hospital, Kobe, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"125","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Barrett,                CE, Park,                J,                Kompaniyets,              L, Baggs,                J, Cheng,                YJ, Zhang,                P, et al.            Intensive Care Unit admission, mechanical ventilation, and mortality            among patients with type 1 diabetes hospitalized for COVID-19 in the          U.S. Diabetes Care          2021;44: 1788\u201396.","DOI":"10.2337\/dc21-0604"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Barron,              E, Bakhai,                C, Kar,                P, Weaver,                A, Bradley,                D, Ismail,                H, et al.            Associations of type 1 and type 2 diabetes with COVID-19-related            mortality in England: a whole-population study. Lancet Diabetes            Endocrinol          2020;8: 813\u201322.","DOI":"10.1016\/S2213-8587(20)30272-2"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Weinreich,                DM,                Sivapalasingam,              S, Norton,                T, Ali,                S, Gao,                H, Bhore,                R, et al.            Trial Investigators. REGN-COV2, a neutralizing            antibody cocktail, in outpatients with Covid-19. N Engl J            Med          2021;384: 238\u201351.","DOI":"10.1056\/NEJMoa2035002"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Chen,              P, Nirula,                A, Heller,                B,              Gottlieb, RL,                Boscia, J,                Morris, J,              et al. BLAZE-1 Investigators.            SARS-CoV-2 neutralizing antibody LY-CoV555 in outpatients with            Covid-19. N Engl J Med          2021;384: 229\u201337.","DOI":"10.1056\/NEJMoa2029849"},{"key":"5","doi-asserted-by":"publisher","unstructured":"5. Gottlieb,                RL, Nirula,                A, Chen,                P, Boscia,                J, Heller,                B, Morris,                J, et al.            Effect of bamlanivimab as monotherapy or in combination with etesevimab            on viral load in patients with mild to moderate COVID-19: a randomized clinical            trial. JAMA          2021;325: 632\u201344.","DOI":"10.1001\/jama.2021.0202"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Wolf,              J, Abzug,                MJ,              Anosike, BI,                Vora, SB,                Waghmare,            A, Sue,                PK, et al.            Updated guidance on use and prioritization of monoclonal antibody therapy            for treatment of COVID-19 in adolescents. J Pediatric Infect Dis            Soc          2022;11: 177\u201385.","DOI":"10.1093\/jpids\/piab124"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Gupta,              A,                Gonzalez-Rojas,              Y, Juarez,                E, Crespo                Casal, M,                Moya, J,                Rodrigues Falci,              D, et al.            COMET-ICE Investigators. Effect of sotrovimab            on hospitalization or death among high-risk patients with mild to moderate COVID-19: a            randomized clinical trial. JAMA          2022;327: 1236\u201346.","DOI":"10.1001\/jama.2022.2832"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Wolfsdorf,                JI, Glaser,                N, Agus,                M, Fritsch,                M, Hanas,                R, Rewers,                A, et al.            ISPAD Clinical Practice Consensus Guidelines 2018: Diabetic ketoacidosis            and the hyperglycemic hyperosmolar state. Pediatr            Diabetes          2018;19(Suppl 27):            155\u201377.","DOI":"10.1111\/pedi.12701"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Gupta,              A,                Gonzalez-Rojas,              Y, Juarez,                E, Crespo                Casal, M,                Moya, J,                Falci, DR,              et al. COMET-ICE Investigators.            Early treatment for Covid-19 with SARS-CoV-2 neutralizing antibody            sotrovimab. N Engl J Med          2021;385: 1941\u201350.","DOI":"10.1056\/NEJMoa2107934"},{"key":"10","unstructured":"10. Center for Drug Evaluation and            Research (CDER) Review. Emergency Use Authorization (EUA) for Sotrovimab          500 mg. https:\/\/www.fda.gov\/media\/150130\/download. (Accessed October 7,          2022)."},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Sardu,              C, D\u2019Onofrio,                N,                Balestrieri,              ML, Barbieri,                M, Rizzo,                MR,              Messina, V,              et al. Outcomes in patients with            hyperglycemia affected by COVID-19: can we do more on glycemic            control?Diabetes Care          2020;43: 1408\u201315.","DOI":"10.2337\/dc20-0723"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Ludvigsson,                JF.            Systematic review of COVID-19 in children shows milder cases and a better            prognosis than adults. Acta Paediatr          2020;109: 1088\u201395.","DOI":"10.1111\/apa.15270"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Kompaniyets,                L, Agathis,                NT, Nelson,                JM,              Preston, LE,                Ko, JY,                Belay, B,              et al. Underlying medical conditions            associated with severe COVID-19 illness among children. JAMA            Netw Open          2021;4: e2111182.","DOI":"10.1001\/jamanetworkopen.2021.11182"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Ho,                J,                Rosolowsky,              E, Pacaud,                D, Huang,                C, Lemay,                JA,                Brockman,            N, et al.            Diabetic ketoacidosis at type 1 diabetes diagnosis in children during the            COVID-19 pandemic. Pediatr Diabetes          2021;22: 552\u20137.","DOI":"10.1111\/pedi.13205"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. McGlacken-Byrne,                SM, Drew,                SEV,              Turner, K,                Peters, C,                Amin,            R. The SARS-CoV-2            pandemic is associated with increased severity of presentation of childhood onset type 1            diabetes mellitus: A multi-centre study of the first COVID-19 wave.            Diabet Med          2021;38: e14640.","DOI":"10.1111\/dme.14640"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Lazzerini,                M, Barbi,                E,              Apicella, A,                Marchetti,              F, Cardinale,                F, Trobia,                G. Delayed            access or provision of care in Italy resulting from fear of COVID-19.            Lancet Child Adolesc Health          2020;4: e10\u20131.","DOI":"10.1016\/S2352-4642(20)30108-5"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Fajgenbaum,                DC, June,                CH. Cytokine            storm. N Engl J Med          2020;383: 2255\u201373.","DOI":"10.1056\/NEJMra2026131"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Ebekozien,                OA, Noor,                N,                Gallagher,              MP, Alonso,                GT. Type 1            Diabetes and COVID-19: preliminary findings from a multicenter surveillance study in the            U.S. Diabetes Care          2020;43: e83\u20135.","DOI":"10.2337\/dc20-1088"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Takashita,                E,                Kinoshita,              N, Yamayoshi,                S,                Sakai-Tagawa,              Y, Fujisaki,                S, Ito,                M, et al.            Efficacy of antiviral agents against the SARS-CoV-2 omicron subvariant            BA.2. N Engl J Med          2022;386: 1475\u20137.","DOI":"10.1056\/NEJMc2201933"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Tao,              K, Tzou,                PL, Kosakovsky                Pond, SL,                Ioannidis,              JPA, Shafer,                RW.            Susceptibility of SARS-CoV-2 omicron variants to therapeutic monoclonal            antibodies: systematic review and meta-analysis. Microbiol            Spectr          2022;10: e0092622.","DOI":"10.1128\/spectrum.00926-22"}],"container-title":["Clinical Pediatric Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/cpe\/32\/2\/32_2022-0077\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:46:43Z","timestamp":1680310003000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/cpe\/32\/2\/32_2022-0077\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1297\/cpe.2022-0077","relation":{},"ISSN":["0918-5739","1347-7358"],"issn-type":[{"value":"0918-5739","type":"print"},{"value":"1347-7358","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023]]},"article-number":"2022-0077"}}